NPC names Dr. Kenneth Finegold as senior vice president of Research and Policy
He joins NPC’s team where he will apply his deep knowledge of the research and evidence used to support federal health policymaking to drive NPC’s policy-
NPC
NPC issues new white paper on 340B Drug Pricing Program
Increases in 340B hospital purchases are associated with $137 in additional annual employer-sponsored premium costs for single coverage and $415 for family coverage.
Whittington, Garrison, and Campbell: Challenges with judging and interpreting a drug’s launch price
A new publication suggests that decision makers take both a product lifetime view and a broader societal perspective when judging and rewarding value creation.
NPC announces Takeda’s Jen Norton as board chair for 2025
NPC’s board also elected its Executive Committee for 2025.